Back to SPPI Stock Lookup
Pages: 1 2 »» Last Page

Spectrum Pharma (SPPI) – Company Press Releases

May 6, 2016 07:00 AM Spectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of the American Urological Association Education and Research Inc. (AUA) in San Diego, California, May
May 5, 2016 04:00 PM Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update
May 3, 2016 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2016 Healthcare Conference on May 10th
Apr 28, 2016 07:00 AM Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast
Apr 20, 2016 07:00 AM FDA Grants Orphan Drug Exclusivity to EVOMELA™ (melphalan) for Injection, Indicated for Multiple Myeloma
Mar 15, 2016 09:00 AM Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval of EVOMELA™ (melphalan) for Injection
Mar 15, 2016 07:00 AM FDA Grants Spectrum Pharmaceuticals Approval of EVOMELA™ (melphalan) for Injection
Mar 9, 2016 04:00 PM Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update
Mar 7, 2016 07:00 AM Spectrum Pharmaceuticals Initiates Phase 2 Breast Cancer Trial for Poziotinib, a Novel Pan-HER Inhibitor
Mar 2, 2016 07:00 AM Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results Teleconference and Webcast
Feb 22, 2016 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at 2016 RBC Capital Markets' Global Healthcare Conference on February 24
Feb 19, 2016 07:00 AM Spectrum Pharmaceuticals Announces FDA’s Acceptance of NDA Filing for EOquin® (apaziquone for intravesical instillation)
Jan 29, 2016 07:00 AM Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Jan 11, 2016 07:00 AM Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada
Dec 16, 2015 07:00 AM Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Dec 15, 2015 01:23 PM TheGrantLawFirm, PLLC Withdraws Action on Behalf of Spectrum Pharmaceuticals, Inc. Purchasers
Dec 10, 2015 08:30 AM Marqibo® Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows Platform
Dec 9, 2015 07:40 PM INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Urges Investors to Contact the Firm
Dec 8, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Four Abstracts on SPI-2012 and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS)
Dec 6, 2015 12:00 PM Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat (Beleodaq®) and Standard CHOP
Dec 4, 2015 07:00 AM Spectrum Pharmaceuticals Highlights 18 Abstracts at the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, December 5-8, 2015
Nov 20, 2015 07:00 AM Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational New Drug (IND) Application for Poziotinib
Nov 18, 2015 03:00 AM Spectrum Pharmaceuticals Divests Rights to ZEVALIN® (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma
Nov 17, 2015 12:11 PM TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers
Nov 12, 2015 10:25 PM DEADLINE ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm
Nov 10, 2015 08:14 PM Lifshitz & Miller Law Firm Announces Investigation of Applied DNA Sciences Inc., Barrett Business Services Inc., First Niagara Financial Group, Fidelity & Guaranty Life, SORL Auto Parts, Inc.,
Nov 4, 2015 07:33 PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Strongly Encourages Shareholders to Contact the Firm
Nov 4, 2015 04:02 PM Eagle Pharmaceuticals and Spectrum Pharmaceuticals Announce Co-Promotion Agreement
Nov 4, 2015 04:01 PM Spectrum Pharmaceuticals Reports Third Quarter 2015 Financial Results and Pipeline Update
Nov 4, 2015 10:52 AM TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers
Nov 2, 2015 07:00 AM Spectrum Pharmaceuticals Announces Third Quarter 2015 Financial Results Teleconference and Webcast
Oct 29, 2015 08:53 PM INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Spectrum Pharmaceuticals, Inc. and Advises Investors to Contact the Firm
Oct 26, 2015 07:00 AM Spectrum Pharmaceuticals Initiates Apaziquone Pivotal Trial for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) Following SPA Agreement
Oct 23, 2015 05:27 PM INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Oct 23, 2015 12:30 AM Spectrum Pharmaceuticals Receives Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA) for EVOMELA™ (melphalan) for Injection
Sep 3, 2015 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw 17th Annual Global Investment Conference on September 10th
Sep 2, 2015 07:00 AM Spectrum Pharmaceuticals Announces Publication of Pivotal EVOMELA™ (melphalan hydrochloride) for Injection Data in the Biology of Blood and Marrow Transplantation Journal
Aug 17, 2015 07:00 AM Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Upcoming Apaziquone Phase 3 Trial in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)
Aug 6, 2015 04:00 PM Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update
Jul 30, 2015 07:00 AM Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jun 24, 2015 07:00 AM Spectrum Pharmaceuticals Announces Publication of Beleodaq® Data Selected as a Rapid Communication in the Journal of Clinical Oncology
May 29, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Five Abstracts of Clinical Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29-June 2, 2015
May 28, 2015 07:00 AM Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd
May 14, 2015 07:00 AM Spectrum Pharmaceuticals Commits to Review Shareholder Proposal
May 7, 2015 04:00 PM Spectrum Pharmaceuticals Reports Continued Advancement of Robust, Late-Stage Pipeline and First Quarter 2015 Financial Results
Apr 30, 2015 07:00 AM Spectrum Pharmaceuticals Announces First Quarter 2015 Financial Results Teleconference and Webcast
Mar 30, 2015 07:00 AM Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability
Mar 13, 2015 07:00 AM Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results
Mar 11, 2015 07:00 AM Four Oncology Key Opinion Leaders to Present at Spectrum Pharmaceuticals’ Analyst Day on Friday, March 13th
Pages: 1 2 »» Last Page

Back to SPPI Stock Lookup